Category Archives: Infectious disease

Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market

The transcript is found here May 19, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, CDC, Congress, FDA, Genetics, Infectious disease, NIH, Oncology | 9 Comments

Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies

July 12, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology | Leave a comment

The Declaration of Pandemics

Posted in - Opinion, - Policy, CDC, CMS, Congress, FDA, Infectious disease, NIH | 6 Comments

The U.S. Military’s Moderna Division Rams Through Another Untested mRNA Gene Therapy

June 1, 2024- by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease, NIH | Leave a comment

Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA

January 19, 2024- by Steven E. Greer, MD

Posted in - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease | 5 Comments

Lancet: Autopsies Show 73% of Sudden Deaths Were Among the Pfizer/Moderna “Vaccinated” Cohort

June 21, 2024-

Posted in - Pharma, - Policy, Cardiology, Emergency medicine, Infectious disease, Internal Medicine, Pediatrics | Leave a comment

The House COVID Select Committee Report on Gov. Cuomo Nursing Home Massacres

September 9, 2024

Posted in - Policy, Congress, Geriatrics, Infectious disease | Leave a comment

Interview with Leslie Manookian, founder of Health Freedom Defense legal fund fighting mask and vaccine mandates

October 6, 2023- by Steven E. Greer, MD

Posted in - Pharma, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Obstetrics and Gynecology | Leave a comment

Florida becomes the first state to recommend against getting the gene therapy “vaccines” for COVID

October 9, 2022- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Harvard, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine | Leave a comment

Ivermectin Cease-and-Desist to The Ohio State University Medical Center

May 18, 2024- by Steven E. Greer, MD I sent the following cease-and-desist after the New York court Order.

Posted in - Opinion, CDC, CMS, Congress, FDA, Infectious disease, NIH, Ohio State | Leave a comment

Greer v. The Lancet 4:23-cv-03761 S.D.T.X.

October 1, 2023- by Steven E. Greer, MD

Posted in - Opinion, CDC, CMS, Congress, FDA, Infectious disease, NIH, Pulmonology | Leave a comment

Rudy Giuliani interviews Steven E. Greer, MD on his podcast TV show: May 15, 2020

May 15, 2020

Posted in - Opinion, - Policy, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

Infectious diseases killed three out of four of Lincoln’s sons

April 8, 2024- by Steven E. Greer, MD

Posted in - Opinion, Infectious disease | Leave a comment

mRNA vaccine boosters and impaired immune system response

February 3, 2024- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease | Leave a comment

Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham

July 7, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH | Leave a comment

Paxlovid causes rebound COVID 25% of the time

January 7, 2024- by Steven E. Greer, MD

Posted in - Pharma, CDC, Emergency medicine, Infectious disease | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment